このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Individually Tailored Balance Training for Older Adults at Risk of Falling (STABLERCT)

2026年11月14日 更新者:Kasper Søndergaard、Copenhagen University Hospital at Herlev

Specific Training According to BaLance Evaluation (STABLE) Versus the Otago Exercise Program for Older Adults With Impaired Balance in Cross-sectoral Rehabilitation: A Double-blind Randomized Controlled Trial

The goal of this clinical trial is to learn whether individually tailored balance training based on the STABLE approach (Specific Training According to BaLance Evaluation) prevents falls better than the Otago Exercise Program in older adults with impaired balance. STABLE uses five simple clinical tests to build a balance profile, from which a physical therapist selects a few home exercises aimed at the person's main balance problems. The main question it aims to answer is: Does STABLE reduce the proportion of participants who fall at least once during the 26 weeks after the training period, compared with the Otago Exercise Program? Researchers will also compare number of falls, injurious falls, hospital admissions, mortality, balance and gait performance, fear of falling, dizziness, physical activity and quality of life.

Participants will:

  • be randomized to STABLE or to the Otago Exercise Program (supplemented with gaze stabilization exercises if they have vestibular dysfunction)
  • perform supervised home exercises for 3 to 4 months with 2 to 6 follow-up physical therapy consultations at the hospital or in their municipal rehabilitation center
  • complete a balance and gait test before and after the training period, measured with a body-worn movement sensor and a force plate
  • answer a short text message (SMS) questionnaire about falls once a week for 26 weeks after the training period Hospital admissions and mortality are collected from medical records 6 and again 24 months after the end of training. Participants' and physical therapists' experiences of the two approaches are explored in qualitative interviews.

調査の概要

詳細な説明

Falls among older adults are common and costly, and exercise, including balance training, reduces the rate of falls, but existing programs have shown only small reductions in the number of people who fall. The Otago Exercise Program (OEP) is the most widely used home-based falls prevention program, but it is only partly tailored to the individual. STABLE is a new approach in which five clinical tests, each measuring a specific balance domain (limits of stability, sensory orientation, reactive stepping, power and turning), form a balance profile that guides the choice of a few targeted home exercises. In a cohort study, 40% fewer patients fell within six months after STABLE-based rehabilitation, but STABLE has not been tested in a controlled trial.

This is a double-blind (participant and outcome assessor), two-arm, parallel-group randomized controlled trial with 1:1 allocation. Over two years, 552 older adults referred for physical therapy assessment of balance at Herlev and Gentofte Hospital or Rigshospitalet, Denmark, are included. Randomization is stratified by the including physical therapist, history of falls before inclusion and planned follow-up setting (hospital or municipality), using randomly permuted blocks of 4 and 6, and is performed automatically in REDCap. Participants receive 3 to 4 months of supervised home exercise according to allocation, followed up at the hospital or in participating municipal rehabilitation centers. A blinded tester measures gait (inertial sensor), standing balance, sit-to-stand power and reach (force plate) and patient-reported outcomes before and after the intervention. Falls are recorded with a weekly SMS questionnaire for 26 weeks after the end-of-treatment test; hospital admissions and mortality are collected from medical records at 6 and 24 months. The primary outcome is the proportion of participants who fall at least once during the 26 weeks, analyzed by intention to treat with multiple imputation. A qualitative study explores participants' and physical therapists' experiences.

研究の種類

介入

入学 (推定)

552

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

      • Herlev、デンマーク、2730
        • Genoptræning og Forebyggelse, Herlev Kommune
        • コンタクト:
      • Rødovre Municipality、デンマーク、2610
        • Genoptræning, Rødovre Kommune
        • コンタクト:
          • Henriette W Bjerrum, BSc
          • 電話番号:004520418153
          • メール:cn26232@rk.dk
      • Ølstykke、デンマーク、3650
        • Sundhed og omsorg, Egedal kommune
        • コンタクト:
    • Region Sjælland
      • Copenhagen、Region Sjælland、デンマーク、2100
        • Copenhagen University Hospital - Rigshospitalet
        • コンタクト:
        • コンタクト:
        • 副調査官:
          • Stefania Serafin, Professor
      • Hellerup、Region Sjælland、デンマーク、2900
        • Copenhagen University Hospital - Herlev and Gentofte Hospital
        • コンタクト:
        • コンタクト:
        • 主任研究者:
          • Kasper Søndergaard, PhD
        • 副調査官:
          • Carsten B Juhl, Professor
        • 副調査官:
          • Anders M Vinther, PhD
        • 副調査官:
          • Jesper Ryg, Professor

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

65年歳以上 (高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Referred to physical therapy assessment of balance at Herlev and Gentofte Hospital or Rigshospitalet
  • Aged 65 years or older
  • Impaired balance at the physical therapy assessment
  • Judged able to carry out home-based self-training
  • Living in a participating municipality (Rødovre, Herlev or Egedal), or, if living elsewhere, judged by the physical therapist to be best rehabilitated with follow-up at the hospital

Exclusion Criteria:

  • Significant cognitive or language limitations preventing self-training or informed consent
  • Declines rehabilitation or participation in the study
  • No balance problems at the physical therapy assessment

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:トリプル

武器と介入

参加者グループ / アーム
介入・治療
実験的:STABLE

Individually tailored home exercise based on the STABLE approach. Exercises are selected from the five STABLE test scores, the patient's goals and overall health condition, typically targeting the primary balance limitations at an appropriate level of difficulty. 3 to 4 months of home exercise with 2 to 6 follow-up physical therapy consultations in which exercises are adjusted.

Specific Training According to BaLance Evaluation (STABLE) is centered on five clinical tests (Maximal reach test [Meach], Test of Reference frame Interaction in Balance [TRIB], Reactive Four Square Step Test [RFSST], Adjusted Sit To Stand test [ASTS], Turn And Touch test [TAT]) measuring five balance domains (limits of stability, sensory orientation, reactive stepping, power, turning) form a balance profile used together with the patient's goals and health condition to select a few targeted home exercises (https://godbalance.dk/). Instructed by a physical therapist at the hospital and followed up at the hospital or in the municipal rehabilitation center for 3 to 4 months.

他の名前:
  • Specific Training According to Balance Evaluation
アクティブコンパレータ:Otago Exercise Program

Home exercise according to the Otago Exercise Program. The level is chosen from the 30-second chair stand test and the 4-Stage Balance Test. Participants with vestibular dysfunction are also instructed in gaze stabilization exercises (GSE). Same number and schedule of follow-up consultations as the STABLE arm.

Otago Exercise Program (OEP) is a standardized home-based strength and balance program (https://www.livestronger.org.nz/assets/Uploads/acc1162-otago-exercise-manual.pdf). Level chosen from the 30-second chair stand test and the 4-Stage Balance Test. Participants with vestibular dysfunction additionally receive gaze stabilization exercises. Same delivery and follow-up as the STABLE arm.

他の名前:
  • OEP
  • Vestibular rehabilitation exercises

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Proportion of participants who fall at least once
時間枠:Weekly for 26 weeks after the end-of-treatment test (approximately 3 to 5 months after baseline)

A fall is defined as an unexpected event in which the participant comes to rest on the ground, floor or lower level, regardless of cause or consequence. Recorded with a weekly SMS questionnaire ("Have you fallen since you last answered this questionnaire?"). Each answer covers all weeks from the previous answer. A fall-related hospital admission in the medical record also counts as a fall. Participants are classified as non-fallers only if all answers are "no", week 26 is answered and no fall-related admission is recorded. Others with incomplete data are imputed. The test SMS sent at the end-of-treatment test does not count. Participants who cannot receive SMS report falls via a relative's phone, or via a paper fall diary returned by post supplemented by a telephone call at 6 months.

Weekly for 26 weeks after the end-of-treatment test (approximately 3 to 5 months after baseline)

二次結果の測定

結果測定
メジャーの説明
時間枠
Number of falls
時間枠:26 weeks after the end-of-treatment test

Total number of falls reported in the weekly SMS (1 to 10, or more than 10, per answer), at least the number of fall-related admissions in the medical record, analyzed as a rate per week covered.

26 weeks after the end-of-treatment test
Number of falls with loss of consciousness
時間枠:26 weeks after the end-of-treatment test

Self-reported in the weekly SMS questionnaire (reason for falling).

26 weeks after the end-of-treatment test
Number of falls with fracture
時間枠:26 weeks after the end-of-treatment test

Self-reported in the weekly SMS questionnaire.

26 weeks after the end-of-treatment test
Hospital admissions
時間枠:6 and 24 months after the end-of-treatment test

Number of all-cause and fall-related hospital admissions, from medical records.

6 and 24 months after the end-of-treatment test
Mortality
時間枠:6 and 24 months after the end-of-treatment test

Vital status and date of death, from medical records.

6 and 24 months after the end-of-treatment test
Rehabilitation courses
時間枠:6 and 24 months after the end-of-treatment test

Number of subsequent rehabilitation courses, from medical records.

6 and 24 months after the end-of-treatment test
Gait performance and movement quality
時間枠:Baseline and end of treatment (approximately 3 to 5 months after baseline)

Seven walking tasks measured with an inertial sensor (Cometa WaveTrack) on the lower back: Timed Up and Go, 3-meter walk, line walking, foam walking with eyes open and closed, figure-of-eight walk and walking over an obstacle. Outcomes: task duration (s), log dimensionless jerk (LDLJ-A), spectral arc length (SPARC), root mean square acceleration (anteroposterior, mediolateral, vertical) and turning velocity. Fastest trial of two per task.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Postural sway
時間枠:Baseline and end of treatment (approximately 3 to 5 months after baseline)

Modified Clinical Test of Sensory Interaction on Balance (firm and foam surface, eyes open and closed, 40 s each) on a force plate (AMTI AccuSway). Centre of pressure (COP) sway measures (e.g. RMS, velocity, sway area) from the middle 30 s, and loss of balance.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Sit-to-stand power
時間枠:Baseline and end of treatment (approximately 3 to 5 months after baseline)

Peak power during a fast sit-to-stand on the force plate (body weight × vertical displacement / time). Best of 2 trials.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Forward reach (limits of stability)
時間枠:Baseline and end of treatment (approximately 3 to 5 months after baseline)

Maximal anterior COP displacement during forward reach on the force plate, expressed as a percentage of the distance from the posterior edge of the medial malleolus to the tip of the big toe. Best of 2 trials.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
STABLE test scores
時間枠:Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)

Scores on the five STABLE tests (Mreach, TRIB, RFSST, ASTS, TAT). Not blinded at the final physical therapy assessment. Assessment not blinded.

Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
Dynamic Gait Index (DGI)
時間枠:Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)

Score 0 to 24, higher is better. Not blinded at the final physical therapy assessment. Assessment not blinded.

Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
4-Stage Balance Test (FSB)
時間枠:Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)

Score 0 to 40, higher is better. Not blinded at the final physical therapy assessment. Assessment not blinded.

Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
30-second chair stand test (30STS)
時間枠:Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)

Score 0 and above, higher is better. Not blinded at the final physical therapy assessment. Assessment not blinded.

Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
Fear of falling
時間枠:Baseline and end of treatment (approximately 3 to 5 months after baseline)

Falls Efficacy Scale-International (FES-I), 16 to 64, higher is more concern.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Dizziness handicap
時間枠:Baseline and end of treatment (approximately 3 to 5 months after baseline)

Dizziness Handicap Inventory (DHI), 0 to 100, higher is more handicap.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Physical activity
時間枠:Baseline and end of treatment (approximately 3 to 5 months after baseline)

Physical Activity Scale for the Elderly (PASE).

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Health-related quality of life
時間枠:Baseline and end of treatment (approximately 3 to 5 months after baseline)

EQ-5D-5L index and EQ VAS.

Baseline and end of treatment (approximately 3 to 5 months after baseline)
Patient-reported global change and tailoring
時間枠:End of treatment (approximately 3 to 5 months after baseline)

Perceived overall change in balance and/or dizziness, perceived tailoring of home exercises and continuity between assessment and exercises (5-point scales).

End of treatment (approximately 3 to 5 months after baseline)

その他の成果指標

結果測定
メジャーの説明
時間枠
Physical therapists' use of test results
時間枠:Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)

Questions answered by the municipal physical therapist at the final assessment of each participant: "Did you use the test results to select or adjust exercises?" (5-point Likert scale).

Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)
Exercise adherence
時間枠:Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)

Self-reported adherence to home exercise (4-point scale), number of exercise sessions per week and duration.

Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)
Adverse effects during exercise
時間枠:End of treatment (approximately 3 to 5 months after baseline)

Frequency, intensity and duration of pain and dizziness during home exercise, falls during exercise, and worsening or new health problems during the training period

End of treatment (approximately 3 to 5 months after baseline)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Kasper Søndergaard, PhD、Copenhagen University Hospital - Herlev and Gentofte and Copenhagen University Hospital - Rigshospitalet

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年11月23日

一次修了 (推定)

2029年10月1日

研究の完了 (推定)

2031年4月1日

試験登録日

最初に提出

2026年11月14日

QC基準を満たした最初の提出物

2026年11月14日

最初の投稿 (実際)

2026年11月20日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月20日

QC基準を満たした最後の更新が送信されました

2026年11月14日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • STABLE-RCT-2026
  • H-26038898 (その他の識別子:The Scientific Ethics Committee of the Capital Region of Denmark)
  • p-2026-21537 (その他の識別子:Research Legal Office, Capital Region of Denmark)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data are not shared publicly, as this is not covered by the ethics and data protection approvals and is restricted by the EU General Data Protection Regulation (GDPR).

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する